PIK3CA(H1047R)-induced paradoxical ERK activation results in resistance to BRAF(V600E) specific inhibitors in BRAFV600E PIK3CA(H1047R) double mutant thyroid tumors
Matthias A Roelli, Dorothee Ruffieux-Daidie, Amandine Stooss, Oussama ElMokh, Wayne A Phillips, Matthias S Dettmer, Roch-Philippe Charles
Oncotarget | IMPACT JOURNALS LLC | Published : 2017
Related Projects (1)
Awarded by Swiss National Science Foundation
Awarded by National Health and Medical Research Council (NHMRC) of Australia
This work was supported by the Swiss National Science Foundation grant 31003A_149824/1. The RPC lab is also supported by the Swiss National Science Foundation grant NCCR-TransCure. WAP is supported, in part, by project grant APP1080491 from the National Health and Medical Research Council (NHMRC) of Australia.